Zydus Cadila Gets DGCI Approval For Phase Three Clinical Trials With Biological Therapy
New Delhi: Drug firm Zydus Cadila has received approval from the Drugs Controller General of India (DCGI) to start phase 3 clinical trials with its biological therapy PegiHep in COVID-19 patients, The New Indian Express (TNIE) reported.…